INCYTE CORPORATION Debt Securities Available For Sale Excluding Accrued Interest
INCYTE CORPORATION (INCY) had Debt Securities Available For Sale Excluding Accrued Interest of $554.71 million as of 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Balance Sheet › Assets
us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest · last filed 2026-04-28
- 2026-03-31: Debt Securities Available For Sale Excluding Accrued Interest $554.71M.
- 2025-12-31: Debt Securities Available For Sale Excluding Accrued Interest $482.79M.
- 2025-09-30: Debt Securities Available For Sale Excluding Accrued Interest $474.81M.
- 2025-06-30: Debt Securities Available For Sale Excluding Accrued Interest $466.77M.
| Period end | Debt Securities Available For Sale Excluding Accrued Interest |
|---|---|
| 2026-03-31 | $554.71M 10-Q · filed 2026-04-28 |
| 2025-12-31 | $482.79M 10-K · filed 2026-02-10 |
| 2025-09-30 | $474.81M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $466.77M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $466.94M 10-Q · filed 2025-04-29 |
| 2024-12-31 | $470.26M 10-K · filed 2025-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |